Emergence of Resistance during β-Lactam Therapy of Gram-Negative Infections
- 1 January 1988
- journal article
- Published by Springer Nature in Drugs
- Vol. 35 (2), 22-28
- https://doi.org/10.2165/00003495-198800352-00007
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Development of -Lactam-Resistant Enterobacter cloacae in MiceThe Journal of Infectious Diseases, 1987
- Combination therapy: a way to limit emergence of resistance?American Journal Of Medicine, 1986
- Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1985
- Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic ratsAntimicrobial Agents and Chemotherapy, 1985
- Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacaeAntimicrobial Agents and Chemotherapy, 1985
- Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1984
- Novel Resistance Selected by the New Expanded-Spectrum Cephalosporins: A ConcernThe Journal of Infectious Diseases, 1983
- A Plasmid-Mediated Cepbalosporinase from Achromobacter SpeciesThe Journal of Infectious Diseases, 1982
- Hydrolysis of Cefotaxime by a beta-lactamase from Bacteroides fragilisAntimicrobial Agents and Chemotherapy, 1980
- Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli.The Journal of Antibiotics, 1980